We are live on
!
Find out more
Squarepoint Portfolio holdings
AUM
$85.1B
1-Year Est. Return
20.93%
This Fund
S&P 500
This Quarter
Est. Return
+2.05%
1 Year Est. Return
+20.93%
3 Year Est. Return
+51.38%
5 Year Est. Return
+34.63%
10 Year Est. Return
+146.23%
AUM
$101B
AUM Growth
+$37.4B
(+59%)
Cap. Flow
+$36.7B
Cap. Flow
% of AUM
36.22%
Top 10 Holdings %
Top 10 Hldgs %
21.17%
Holding
5,633
New
1,585
Increased
2,056
Reduced
1,281
Closed
669
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.43B |
| 2 |
NVIDIA
NVDA
|
+$1.29B |
| 3 |
Apple
AAPL
|
+$690M |
| 4 |
Microsoft
MSFT
|
+$376M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$340M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$2.67B |
| 2 |
State Street Real Estate Select Sector SPDR ETF
XLRE
|
+$204M |
| 3 |
SPDR Gold Trust
GLD
|
+$173M |
| 4 |
Costco
COST
|
+$161M |
| 5 |
Qualcomm
QCOM
|
+$142M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.66% |
| 2 | Consumer Discretionary | 5.03% |
| 3 | Financials | 3.61% |
| 4 | Healthcare | 3.25% |
| 5 | Industrials | 3.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4851
Alto Ingredients
ALTO
$360M
| $44.2K | ﹤0.01% |
+28,347
| New | +$44.5K |
|
|
SRG
4852
PUT
Seritage Growth Properties
SRG
$130M
| $43.7K | ﹤0.01% |
+10,600
| New | +$45.6K |
|
4853
Allogene Therapeutics
ALLO
$601M
| $43.3K | ﹤0.01% |
20,345
-168,152
| -89% | -$415K |
|
4854
Kyverna Therapeutics
KYTX
$450M
| $43K | ﹤0.01% |
+11,488
| New | +$55K |
|
4855
SOPHiA GENETICS
SOPH
$480M
| $42.9K | ﹤0.01% |
13,753
-5,886
| -30% | -$20K |
|
4856
IGC Pharma
IGC
$27.6M
| $42.3K | ﹤0.01% |
+125,966
| New | +$47.1K |
|
|
SOND
4857
DELISTED
Sonder
SOND
| $42.1K | ﹤0.01% |
+13,253
| New | +$46.9K |
|
4858
GoPro
GPRO
$116M
| $42K | ﹤0.01% |
+38,543
| New | +$49K |
|
|
DM
4859
DELISTED
Desktop Metal, Inc.
DM
| $41.2K | ﹤0.01% |
+17,608
| New | +$74.6K |
|
4860
CALL
Sundial Growers
SNDL
$325M
| $41K | ﹤0.01% |
+22,900
| New | +$44.9K |
|
4861
Rimini Street
RMNI
$408M
| $40K | ﹤0.01% |
+14,966
| New | +$30.5K |
|
4862
Genelux
GNLX
$130M
| $39.8K | ﹤0.01% |
16,859
-9,798
| -37% | -$26.1K |
|
4863
Tango Therapeutics
TNGX
$4.34B
| $39.7K | ﹤0.01% |
+12,843
| New | +$59.6K |
|
|
PRPH
4864
DELISTED
ProPhase Labs
PRPH
| $39.7K | ﹤0.01% |
+5,239
| New | +$73.5K |
|
|
TTOO
4865
DELISTED
T2 Biosystems, Inc
TTOO
| $39.1K | ﹤0.01% |
+92,983
| New | +$77.7K |
|
4866
CALL
RLX Technology
RLX
$2.48B
| $38.7K | ﹤0.01% |
+17,900
| New | +$32.2K |
|
|
CAN
4867
PUT
Canaan Creative
CAN
$176M
| $38.5K | ﹤0.01% |
+18,800
| New | +$31.8K |
|
4868
Skye Bioscience
SKYE
$22.9M
| $38.3K | ﹤0.01% |
+13,546
| New | +$56.6K |
|
|
RVNC
4869
CALL
DELISTED
Revance Therapeutics, Inc.
RVNC
| $38.3K | ﹤0.01% |
+12,600
| New | +$54.9K |
|
4870
AXT Inc
AXTI
$3.09B
| $38K | ﹤0.01% |
17,523
-56,686
| -76% | -$129K |
|
4871
Ring Energy
REI
$322M
| $37.6K | ﹤0.01% |
+27,639
| New | +$41.5K |
|
4872
Kartoon Studios
TOON
$34.3M
| $37.1K | ﹤0.01% |
+62,930
| New | +$44.8K |
|
4873
CALL
Innoviz Technologies
INVZ
$135M
| $37K | ﹤0.01% |
+22,000
| New | +$18.2K |
|
4874
Intellicheck
IDN
$73.5M
| $36.7K | ﹤0.01% |
13,121
-13,879
| -51% | -$34.9K |
|
4875
TMC The Metals Company
TMC
$1.59B
| $36.6K | ﹤0.01% |
32,718
+11,904
| +57% | +$11.2K |
|
Similar funds
Squarepoint's Q4 2024 Portfolio in Review
As of Q4 2024, Squarepoint held 5,633 positions worth $101B, up 59% from $63.9B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Squarepoint deployed $36.7B of net new capital in Q4 2024, opening 1,585 new positions and adding to 2,056 existing holdings. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 2,432,087 shares worth $1.43B.
By sector, the portfolio is most concentrated in Technology at 9.7% of assets, up from 9% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was iShares Core S&P 500 ETF, an estimated $2.67B trimmed.
- Squarepoint's largest Q4 2024 buy was State Street SPDR S&P 500 ETF Trust: 2,432,087 shares worth $1.43B.
- Squarepoint added most to NVIDIA in Q4 2024, an estimated $1.29B increase.
- Squarepoint's biggest Q4 2024 reduction was iShares Core S&P 500 ETF, cutting an estimated $2.67B.
- Squarepoint fully exited State Street Financial Select Sector SPDR ETF in Q4 2024, selling an estimated $86.3M.
- Squarepoint's ten largest holdings make up 21% of its $101B portfolio in Q4 2024.
- Squarepoint opened 1,585 new positions and closed 669 in Q4 2024.
- Squarepoint's portfolio value rose 59% quarter-over-quarter to $101B.
Based on Squarepoint's 13F filing for Q4 2024, filed 14 Feb 2025.